advertisement

---

Pharmaceutics 9

Showing records 1 to 9 | Display all abstracts in Pharmaceutics

118457 Exploring the Ocular Absorption Pathway of Fasudil Hydrochloride towards Developing a Nanoparticulate Formulation with Improved Performance
Osi B
Pharmaceutics 2024; 16:

---

118499 Therapeutic Aqueous Humor Concentrations of Latanoprost Attained in Rats by Administration in a Very-High-Molecular-Weight Hyaluronic Acid Eye Drop
Higa K
Pharmaceutics 2024; 16:

---

117215 Chemical Insights into Topical Agents in Intraocular Pressure Management: From Glaucoma Etiopathology to Therapeutic Approaches
Patton GN; Lee HJ
Pharmaceutics 2024; 16:

---

118457 Exploring the Ocular Absorption Pathway of Fasudil Hydrochloride towards Developing a Nanoparticulate Formulation with Improved Performance
Al-Kinani AA
Pharmaceutics 2024; 16:

---

118499 Therapeutic Aqueous Humor Concentrations of Latanoprost Attained in Rats by Administration in a Very-High-Molecular-Weight Hyaluronic Acid Eye Drop
Kimoto R
Pharmaceutics 2024; 16:

---

118457 Exploring the Ocular Absorption Pathway of Fasudil Hydrochloride towards Developing a Nanoparticulate Formulation with Improved Performance
Al-Qaysi ZK
Pharmaceutics 2024; 16:

---

118499 Therapeutic Aqueous Humor Concentrations of Latanoprost Attained in Rats by Administration in a Very-High-Molecular-Weight Hyaluronic Acid Eye Drop
Kojima T; Dogru M
Pharmaceutics 2024; 16:

---

118457 Exploring the Ocular Absorption Pathway of Fasudil Hydrochloride towards Developing a Nanoparticulate Formulation with Improved Performance
Khoder M; Alany RG
Pharmaceutics 2024; 16:

---

118499 Therapeutic Aqueous Humor Concentrations of Latanoprost Attained in Rats by Administration in a Very-High-Molecular-Weight Hyaluronic Acid Eye Drop
Müller-Lierheim WGK; Shimazaki J
Pharmaceutics 2024; 16:

---